The correlation between rheumatoid factor and anti cyclic citrullinated peptides with gene expression of FoxP3 in rheumatoid artheritis patients

The correlation between rheumatoid factor and anti cyclic citrullinated peptides with gene expression of FoxP3 in rheumatoid artheritis patients

Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affect 1-2% of people worldwide. Inflammation is an important factor in the pathogenesis of RA. Anti- Cyclic Citrullinated Peptid (Anti-CCP) antibody and Rheumatoid Factor (RF) are autoantibodies that promotes inflammatory...

Full description

Bibliographic Details
Main Authors:	Nasrin Iranshahi, Seyed Mojtaba Amiri, Parisa Zafari, Mahdi Taghaddosi
Format:	Article
Language:	English
Published:	Negah Institute for Scientific Communication 2018-01-01
Series:	International Journal of Biomedicine and Public Health
Subjects:	rheumatoid arthritis foxp3 rheumatoid factor anti-ccp
Online Access:	http://www.ijbmph.com/article_55339_5e8ab3e0abfb07fd153ecfb17d8e83e6.pdf

Similar Items

Diagnostic value of simultaneous use of anti-cyclic citrulinated peptide and rheumatoid factor in rheumatoid arthritis
by: Azarhoush R, et al.
Published: (2013-09-01)

Effect of anti - cyclic citrullinated peptide antibody and Rheumatoid factor on clinical diseases activity index in patients with rheumatoid arthritis
by: Jafarzadeh L, et al.
Published: (2015-09-01)

Relationship between vitamin D plasma level and Foxp3 gene expression among rheumatoid arthritis patients
by: Zafari P, et al.
Published: (2018-02-01)

Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Isotypes in Iranian Patients with Rheumatoid Arthritis: Evaluation of Clinical Value and Association with Disease Activity
by: Yadollah Shakiba, et al.
Published: (2014-06-01)

The impact of anti-cyclic citrullinated peptide antibody status on the management of patients with early rheumatoid arthritis: observational study results from Lithuania
by: Sigita Stropuvienė, et al.
Published: (2018-08-01)

Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
by: H.M. Farouk, et al.
Published: (2009-09-01)

Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic
by: Prabhakar Singh, et al.
Published: (2020-01-01)

Associação do anticorpo anticitrulina e gravidade da artrite reumatóide Association of anti-cyclic citrullinated peptide antibody and severe rheumatoid arthritis
by: Aldifran Ferreira da Silva, et al.
Published: (2006-06-01)

Increased gene expression of CCR6 and RORγt in peripheral blood cells of rheumatoid arthritis patients and their correlation with anti‐cyclic citrullinated peptide and disease activity
by: Seyed Askar Roghani, et al.
Published: (2023-12-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology
by: Natalia Sherina, et al.
Published: (2017-09-01)

Investigating the potential correlation between vitamin D with rheumatoid factor, anticyclic citrullinated peptides antibody, and interleukin-12 levels in rheumatoid arthritis women in Erbil, Iraq
by: Nasrin Mostafa Amjadipoor, et al.
Published: (2023-01-01)

Diagnostic Usefulness of Anti-Cyclic Citrullinated Peptide and Anti-Mutated Citrullinated Vimentin Antibodies in the Diagnosis of Seronegative Rheumatoid Arthritis Patients
by: Bushra Gohar Shah , Asma Saeed , Mohammad Faisal Khan , Hamid Javaid Quershi
Published: (2016-03-01)

Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives
by: Johan Rönnelid, et al.
Published: (2021-05-01)

The Role of Anti-cyclic Citrullinated Peptide Antibody from Joint to Brain
by: Rokhsareh Meamar, et al.
Published: (2014-02-01)

Onset of polyarticular juvenile idiopathic arthritis with both anti-cyclic citrullinated peptide antibodies and rheumatoid factor in a 3-year-old girl
by: Yasui Kozo, et al.
Published: (2012-12-01)

Anti-Cyclic Citrullinated Peptide Frequency in Patients with Chronic Hepatitis C Virus Infection and Effect of Presence of Systemic Disease
by: Serkan Cerrah, et al.
Published: (2012-12-01)

‘Preclinical’ rheumatoid arthritis in patients with celiac disease: A cross-sectional study
by: Beenish Fayyaz, et al.
Published: (2019-03-01)

Possible Role of Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Rheumatic Diseases
by: Eman Sh Al-Obeidy, et al.
Published: (2019-11-01)

Possible Role of Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Rheumatic Diseases
by: Eman Sh Al-Obeidy, et al.
Published: (2019-11-01)

Frequency of Positive Anti-CCP Antibodies in Patients of Rheumatoid Arthritis with Negative Rheumatoid Factor: A Cross-sectional Retrospective Data-based Study
by: Nauman Ismat Butt, et al.
Published: (2024-08-01)

The Association of Anti-CCP and Disease Activity in Rheumatoid Arthritis
by: Raouf Rahim Merza, et al.
Published: (2014-08-01)

Risk Factors and Early Detection of Diabetes Mellitus in Early Rheumatoid Arthritis Women
by: Mohammad H. Ali, et al.
Published: (2018-04-01)

Comparism between Anti-RA33, Anti-CCP antibodies and Rheumatoid Factor in the Diagnosis of Rheumatoid Arthritis in Iraqi Patients
by: Ammar H. Al-Ubaidi, et al.
Published: (2013-04-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
by: S.L.E. Ribeiro, et al.
Published: (2008-11-01)

Association of rs2232365 polymorphism in promoter of FOXP3 gene with the incidence of rheumatoid arthritis in Iranian population
by: Nasimeh Mahmoodi, et al.
Published: (2019-10-01)

A Study of CD4+Foxp3+Treg and CD8+Foxp3+Treg Cells in Patients with Rheumatoid Arthritis
by: Mahtab Tapak, et al.
Published: (2011-11-01)

Discriminant Analysis of Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide, and C-Reactive Protein for Rheumatoid Arthritis Patients
by: Ausaf Ahmad, et al.
Published: (2017-03-01)

Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis
by: Monika Gudowska, et al.

Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
by: Laura C. Cappelli, et al.
Published: (2018-03-01)

7- DIAGNOSTIC VALUE OF ANTIBODIES TO CITRULLINE CONTAINING PEPTIDES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SOUTHERN IRAQ43
by: THURAYA J MEZAL, et al.
Published: (2009-06-01)

Rheumatoid Arthritis-Associated Autoimmunity Due to Aggregatibacter actinomycetemcomitans and Its Resolution With Antibiotic Therapy
by: Amarshi Mukherjee, et al.
Published: (2018-10-01)

Diagnostic value of Anti-CCP antibodies compared with Rheumatoid factor in Rheumatoid arthritis patients.
by: Hanaa N. Abdullah, et al.
Published: (2013-08-01)

Decreased Level of Vitamin D is Associated with Rheumatoid Arthritis Patients from Western Region of Nepal
by: Basant Kumar Tamrakar, et al.
Published: (2018-12-01)

Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
by: N. V. Bunchuk
Published: (2023-01-01)

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
by: Tomoya Shibahara, et al.
Published: (2016-07-01)

Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance
by: Laura Martinez-Prat, et al.
Published: (2018-06-01)

Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
by: Juan Irure-Ventura, et al.
Published: (2025-01-01)

Association of rheumatoid factor and anti-cyclic citrullinated peptide antibody with demographic, clinical, and inflammatory parameters in rheumatoid arthritis
by: Rajat Sarkar, et al.
Published: (2023-01-01)